BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38891059)

  • 1. Chronological and Biological Aging in Amyotrophic Lateral Sclerosis and the Potential of Senolytic Therapies.
    Dashtmian AR; Darvishi FB; Arnold WD
    Cells; 2024 May; 13(11):. PubMed ID: 38891059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics: A Novel Strategy for Neuroprotection in ALS?
    Maximova A; Werry EL; Kassiou M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Jankovic M; Novakovic I; Gamil Anwar Dawod P; Gamil Anwar Dawod A; Drinic A; Abdel Motaleb FI; Ducic S; Nikolic D
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients.
    Allen SP; Duffy LM; Shaw PJ; Grierson AJ
    Neurobiol Aging; 2015 Oct; 36(10):2893-903. PubMed ID: 26344876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research advances in amyotrophic lateral sclerosis, 2009 to 2010.
    Traub R; Mitsumoto H; Rowland LP
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):67-77. PubMed ID: 21080240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective.
    Pandya VA; Patani R
    Brain; 2020 Apr; 143(4):1057-1072. PubMed ID: 31851317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial pathobiology in ALS.
    Martin LJ
    J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis.
    Ziff OJ; Patani R
    Aging Cell; 2019 Feb; 18(1):e12862. PubMed ID: 30565851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Fukunaga K; Shinoda Y; Tagashira H
    J Pharmacol Sci; 2015 Jan; 127(1):36-41. PubMed ID: 25704016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
    Belosludtseva NV; Matveeva LA; Belosludtsev KN
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications.
    Nakagawa Y; Yamada S
    Eur J Pharmacol; 2021 Feb; 892():173737. PubMed ID: 33220280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis.
    Duffy LM; Chapman AL; Shaw PJ; Grierson AJ
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):336-52. PubMed ID: 21299590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis.
    Sabatelli M; Marangi G; Conte A; Tasca G; Zollino M; Lattante S
    Brain Pathol; 2016 Mar; 26(2):266-75. PubMed ID: 26780671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
    Kawamata H; Manfredi G
    Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis.
    Genin EC; Abou-Ali M; Paquis-Flucklinger V
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.
    Tan W; Pasinelli P; Trotti D
    Biochim Biophys Acta; 2014 Aug; 1842(8):1295-301. PubMed ID: 24568860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial involvement in amyotrophic lateral sclerosis.
    Menzies FM; Ince PG; Shaw PJ
    Neurochem Int; 2002 May; 40(6):543-51. PubMed ID: 11850111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.